Regarding the perspective on IDO1-centered dormancy regulation, while current research has devoted to the development of IDO1 inhibitors for active tumour elimination, how these inhibitors may be applied in dormancy models needs further attention. The gene discussed is IDO1; the disease is neoplasm.